172 related articles for article (PubMed ID: 35138101)
61. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
62. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
63. Lack of O-GlcNAcylation enhances exercise-dependent glucose utilization potentially through AMP-activated protein kinase activation in skeletal muscle.
Murata K; Morino K; Ida S; Ohashi N; Lemecha M; Park SY; Ishikado A; Kume S; Choi CS; Sekine O; Ugi S; Maegawa H
Biochem Biophys Res Commun; 2018 Jan; 495(2):2098-2104. PubMed ID: 29253568
[TBL] [Abstract][Full Text] [Related]
64. Chemical tools to explore nutrient-driven O-GlcNAc cycling.
Kim EJ; Bond MR; Love DC; Hanover JA
Crit Rev Biochem Mol Biol; 2014; 49(4):327-42. PubMed ID: 25039763
[TBL] [Abstract][Full Text] [Related]
65. Dual functionality of O-GlcNAc transferase is required for Drosophila development.
Mariappa D; Zheng X; Schimpl M; Raimi O; Ferenbach AT; Müller HA; van Aalten DM
Open Biol; 2015 Dec; 5(12):150234. PubMed ID: 26674417
[TBL] [Abstract][Full Text] [Related]
66. A two-layered machine learning method to identify protein O-GlcNAcylation sites with O-GlcNAc transferase substrate motifs.
Kao HJ; Huang CH; Bretaña NA; Lu CT; Huang KY; Weng SL; Lee TY
BMC Bioinformatics; 2015; 16 Suppl 18(Suppl 18):S10. PubMed ID: 26680539
[TBL] [Abstract][Full Text] [Related]
67. Identification of novel O-GlcNAc transferase substrates using yeast cells expressing OGT.
Li F; Yang G; Tachikawa H; Shao K; Yang Y; Gao XD; Nakanishi H
J Gen Appl Microbiol; 2021 Apr; 67(1):33-41. PubMed ID: 33229814
[TBL] [Abstract][Full Text] [Related]
68. Hepatocyte nuclear factor 1 alpha (HNF1A) regulates transcription of O-GlcNAc transferase in a negative feedback mechanism.
Zhang C; Xie F; Li L; Zhang C; Zhang Y; Ying W; Liu L; Yan X; Yin F; Zhang L
FEBS Lett; 2019 May; 593(10):1050-1060. PubMed ID: 30953348
[TBL] [Abstract][Full Text] [Related]
69. Functional significance of O-GlcNAc modification in regulating neuronal properties.
Hwang H; Rhim H
Pharmacol Res; 2018 Mar; 129():295-307. PubMed ID: 29223644
[TBL] [Abstract][Full Text] [Related]
70. '
Zhao L; Shah JA; Cai Y; Jin J
Molecules; 2018 Aug; 23(8):. PubMed ID: 30082668
[TBL] [Abstract][Full Text] [Related]
71. Novel bisubstrate uridine-peptide analogues bearing a pyrophosphate bioisostere as inhibitors of human O-GlcNAc transferase.
Ryan P; Shi Y; von Itzstein M; Rudrawar S
Bioorg Chem; 2021 May; 110():104738. PubMed ID: 33667901
[TBL] [Abstract][Full Text] [Related]
72. O-GlcNAc cycling enzymes associate with the translational machinery and modify core ribosomal proteins.
Zeidan Q; Wang Z; De Maio A; Hart GW
Mol Biol Cell; 2010 Jun; 21(12):1922-36. PubMed ID: 20410138
[TBL] [Abstract][Full Text] [Related]
73. O-GlcNAcylation under hypoxic conditions and its effects on the blood-retinal barrier in diabetic retinopathy.
Xu C; Liu G; Liu X; Wang F
Int J Mol Med; 2014 Mar; 33(3):624-32. PubMed ID: 24366041
[TBL] [Abstract][Full Text] [Related]
74. Cross regulation between mTOR signaling and O-GlcNAcylation.
Very N; Steenackers A; Dubuquoy C; Vermuse J; Dubuquoy L; Lefebvre T; El Yazidi-Belkoura I
J Bioenerg Biomembr; 2018 Jun; 50(3):213-222. PubMed ID: 29524020
[TBL] [Abstract][Full Text] [Related]
75. OGT as potential novel target: Structure, function and inhibitors.
Zhang N; Jiang H; Zhang K; Zhu J; Wang Z; Long Y; He Y; Feng F; Liu W; Ye F; Qu W
Chem Biol Interact; 2022 Apr; 357():109886. PubMed ID: 35288161
[TBL] [Abstract][Full Text] [Related]
76. Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification.
Vosseller K; Sakabe K; Wells L; Hart GW
Curr Opin Chem Biol; 2002 Dec; 6(6):851-7. PubMed ID: 12470741
[TBL] [Abstract][Full Text] [Related]
77. O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation.
Zhu Q; Zhou L; Yang Z; Lai M; Xie H; Wu L; Xing C; Zhang F; Zheng S
Med Oncol; 2012 Jun; 29(2):985-93. PubMed ID: 21461968
[TBL] [Abstract][Full Text] [Related]
78. Identification and characterization of a missense mutation in the
Vaidyanathan K; Niranjan T; Selvan N; Teo CF; May M; Patel S; Weatherly B; Skinner C; Opitz J; Carey J; Viskochil D; Gecz J; Shaw M; Peng Y; Alexov E; Wang T; Schwartz C; Wells L
J Biol Chem; 2017 May; 292(21):8948-8963. PubMed ID: 28302723
[No Abstract] [Full Text] [Related]
79. Implications of the O-GlcNAc modification in the regulation of nuclear apoptosis in T cells.
Johnson B; Opimba M; Bernier J
Biochim Biophys Acta; 2014 Jan; 1840(1):191-8. PubMed ID: 24035784
[TBL] [Abstract][Full Text] [Related]
80. A highly effective and adjustable dual plasmid system for O-GlcNAcylated recombinant protein production in E. coli.
Han C; Shan H; Bi C; Zhang X; Qi J; Zhang B; Gu Y; Yu W
J Biochem; 2015 Jun; 157(6):477-84. PubMed ID: 25619971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
